| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 17
| Issue : 3 | Page : 281-286 |
|
|
Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime
Thomas Iype1, Ayyappan Kunjukrishna Pillai1, Ajith Cherian1, Zinia T Nujum2, Chithra Pushpa1, Dalus Dae3, Vijayakumar Krishnapillai2
1 Department of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India
2 Department of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India
3 Department of Medicine, Government Medical College, Thiruvananthapuram, Kerala, India
Correspondence Address:
Thomas Iype
Department of Neurology, Government Medical College, Thiruvananthapuram - 695 011, Kerala
India
 Source of Support: State Board of Medical Research, Government of Kerala, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-2327.138496
|
|
|
Background: Revised National Tuberculosis Control Programme (RNTCP) of Government of India provides intermittent thrice-a-week directly observed treatment short course (RNTCP regimen). Objective: Assessments of all-cause mortality and nine-month morbidity outcomes of patients with tuberculous meningitis (TBM) on RNTCP regimen. Materials and Methods: We prospectively followed up patients registered with RNTCP center, with a diagnosis of TBM from January 1 st , 2010 to December 31 st , 2011. Morbidity was assessed using modified Rankin Scale (mRS). Results: We had 43 patients with median duration for follow-up of 396 days and that of survivors of 425 days. Two patients defaulted. Fourteen patients (32.5%) had mRS score of 4 to 6 and 29 had mRS of 0 to 3 after 9-month treatment. Severe disability was not related to any factor on logistic regression. Severe disability was seen in one patient (6.66%) among the 15 patients with stage 1, nine (37.5%) out of 24 patients with stage 2 and three (75%) out of 4 patients with stage 3 disease. Eight patients died (18.6%) of whom 4 died during the intensive phase and 4 during the continuation phase of RNTCP regimen. Mortality was independently related to treatment failure with adjusted Hazard ratio of 8.29 (CI: 1.38-49.78) (P = 0.02). One patient (6.66%) died out of the 15 patients with stage 1 disease, 5 (20.8%) out of 24 patients with stage 2 disease and 2 (50%) out of the 4 with stage 3 disease. Discussion and Conclusion: RNTCP regimen was associated with good compliance, comparable mortality and morbidity. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
